| Nov 7 |
Treace Medical Concepts Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 6 |
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
|
| Nov 4 |
Treace Announces Participation in the UBS Global Healthcare Conference
|
| Nov 4 |
Treace Comments on CMS’ 2025 Final Rule for Hospital Outpatient and ASC Settings
|
| Nov 4 |
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
|
| Oct 22 |
Treace to Report Third Quarter 2024 Financial Results on November 5, 2024
|
| Oct 14 |
Treace Files Patent Infringement and Unfair Competition Suit to Protect Lapiplasty® Bunion Technology
|
| Oct 9 |
Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst ...
|
| Sep 11 |
Treace Highlights New Product Innovations and Updated Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2024
|
| Aug 22 |
Treace Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
|
